Adverse Events and Tolerability of Combined Durvalumab and Tremelimumab versus Durvalumab Alone in Solid Cancers: A Systematic Review and Meta-Analysis

Fahmy, O; Ahmed, OAA; Khairul-Asri, MG; Alhakamy, NA; Alharbi, WS; Fahmy, UA; El-Moselhy, MA; Fresta, CG; Caruso, G; Caraci, F

Caruso, G (通讯作者)，Univ Catania, Dept Drug & Hlth Sci, I-95125 Catania, Italy.;Caruso, G (通讯作者)，Oasi Res Inst IRCCS, Unit Neuropharmacol & Translat Neurosci, I-94018 Troina, Italy.

BIOMEDICINES, 2022; 10 (5):

Abstract

Background: Recently, the combination of durvalumab and tremelimumab, two immune checkpoint inhibitors, for the treatment of different types of cancer......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索